NEW HAVEN, Conn., April 3, 2019 /PRNewswire/ -- (NYSE: BHVN) - Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced the appointment of William "BJ" Jones as Chief Commercial Officer, Migraine and Common Diseases. Mr. Jones will have oversight of the commercial...